Coya Therapeutics Relocates Principal Executive Offices
Ticker: COYA · Form: 8-K · Filed: Aug 19, 2024 · CIK: 1835022
| Field | Detail |
|---|---|
| Company | Coya Therapeutics, Inc. (COYA) |
| Form Type | 8-K |
| Filed Date | Aug 19, 2024 |
| Risk Level | low |
| Pages | 4 |
| Reading Time | 5 min |
| Key Dollar Amounts | $0.0001, $425,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-action, office-relocation
TL;DR
Coya Therapeutics moved its HQ to 5850 San Felipe St., Houston, TX 77057, effective Aug 16.
AI Summary
Coya Therapeutics, Inc. announced on August 16, 2024, a change in its principal executive offices to 5850 San Felipe St., Suite 500, Houston, Texas 77057. This move from their previous address at 12645 Memorial Dr., Suite F1 #305, Houston, TX 77024, is effective immediately. The company also updated its principal business address.
Why It Matters
A change in principal executive offices can indicate operational shifts or growth for a company. Investors should monitor if this move is associated with any strategic changes or cost implications.
Risk Assessment
Risk Level: low — This filing solely reports a change in the company's principal executive offices, which is a routine administrative update with no immediate financial or operational risks.
Key Players & Entities
- Coya Therapeutics, Inc. (company) — Registrant
- 5850 San Felipe St., Suite 500, Houston, Texas 77057 (location) — New Principal Executive Offices
- 12645 Memorial Dr., Suite F1 #305, Houston, TX 77024 (location) — Previous Principal Executive Offices
- August 16, 2024 (date) — Effective date of office change
FAQ
What is the new address for Coya Therapeutics' principal executive offices?
The new address for Coya Therapeutics' principal executive offices is 5850 San Felipe St., Suite 500, Houston, Texas 77057.
When was the change in principal executive offices effective?
The change in principal executive offices was effective August 16, 2024.
What was Coya Therapeutics' previous principal executive office address?
Coya Therapeutics' previous principal executive office address was 12645 Memorial Dr., Suite F1 #305, Houston, TX 77024.
Is this change related to any specific business event or transaction?
The filing does not specify any particular business event or transaction prompting the change in principal executive offices; it is reported as a current report event.
What is the business phone number listed for Coya Therapeutics?
The business phone number listed for Coya Therapeutics is 800-587-8170.
Filing Stats: 1,187 words · 5 min read · ~4 pages · Grade level 10.8 · Accepted 2024-08-19 09:10:00
Key Financial Figures
- $0.0001 — ich registered Common Stock, par value $0.0001 per share COYA The Nasdaq Stock Mar
- $425,000 — r. Swaminathan's current base salary is $425,000, and Dr. Swaminathan is eligible to rec
Filing Documents
- d861081d8k.htm (8-K) — 33KB
- d861081dex101.htm (EX-10.1) — 43KB
- d861081dex991.htm (EX-99.1) — 14KB
- 0001193125-24-202551.txt ( ) — 233KB
- coya-20240816.xsd (EX-101.SCH) — 3KB
- coya-20240816_lab.xml (EX-101.LAB) — 18KB
- coya-20240816_pre.xml (EX-101.PRE) — 11KB
- d861081d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 10.1 Executive Employment Agreement by and between the Company and Arun Swaminathan, dated April 3, 2023. 99.1 Press Release, dated August 19, 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). -3-
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. COYA THERAPEUTICS, INC. Date: August 19, 2024 By: /s/ Howard Berman Name: Howard Berman Title: Chief Executive Officer -4-